作者: Sanne Lysbet De Haas , Stefan Scherer , Peter Carmeliet , Diether Lambrechts
DOI:
关键词:
摘要: The invention is concerned with a method of determining whether patient more suitably treated by therapy an angiogenesis inhibitor, such as bevacizumab, determing the genotype VEGFR-1 gene. further relates to pharmaceutical composition comprising for treatment suffering from cancer based on improving effect chemotherapy adding